DRG explant model for understanding mechanism of oxaliplatin-induced peripheral neuropathy and identifying potential therapeutic targets

Authors

• Junwei Du, Washington University School of Medicine in St. Louis
• Leland C Sudlow, Washington University School of Medicine in St. Louis
• Igor D Luzhansky, Washington University School of Medicine in St. Louis
• Mikhail Y Berezin, Washington University School of Medicine in St. Louis

Journal

Antioxidants

Publication Date

2-10-2026

Volume

15

Issue

2

First Page

230

Document Type

Open Access Publication

DOI

10.3390/antiox15020230

Rights and Permissions

Du J, Sudlow LC, Luzhansky ID, Berezin MY. DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets. Antioxidants (Basel). 2026 Feb 10;15(2):230. doi: 10.3390/antiox15020230. © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Recommended Citation

Du, Junwei; Sudlow, Leland C; Luzhansky, Igor D; and Berezin, Mikhail Y, "DRG explant model for understanding mechanism of oxaliplatin-induced peripheral neuropathy and identifying potential therapeutic targets." Antioxidants. 15, 2. 230 (2026).
https://digitalcommons.wustl.edu/oa_4/7751

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.